Unified Patent Court (UPC) analytics are now available. Check here

IP Verse

Zaklady Farmaceutyczne Polpharma patent opposition analysis

Get Patent Opposition Report for Zaklady Farmaceutyczne Polpharma

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Latest oppositions filed by Zaklady Farmaceutyczne Polpharma

Explore patent oppositions filed by Zaklady Farmaceutyczne Polpharma against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP3529360Methods For Preventing Cardiovascular Events Through Proprotein Convertase Subtilisin Kexin 9 (Pcsk9) Protein ReductionNOVARTISJan 15, 2025
EP3474820Glp-1 Compositions And Uses ThereofNOVO NORDISKNov 7, 2024
EP2395968Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIMOct 10, 2024
EP3595667Pharmaceutical Compositions Comprising A Jak InhibitorALFASIGMASep 20, 2024
EP3999643Methods Of Treating Or Preventing Spinal Muscular AtrophyBIOGEN MAAug 20, 2024
EP3270909Fixed Dose Combinations Comprising Etc1002 And One Or More Statins For Treating Or Reducing Cardiovascular RiskESPERION THERAPEUTICSJul 31, 2024
EP3626270New UseNOVARTISJul 10, 2024
EP3542790Compositions Comprising A Delivery Agent And Preparation ThereofNOVO NORDISKJun 13, 2024
EP3110449Medical Use Of A Dpp-4 InhibitorBOEHRINGER INGELHEIMMar 26, 2024
EP3488857Compositions Of Glp-1 Peptides And Preparation ThereofNOVO NORDISKMar 7, 2024

Top competitors of Zaklady Farmaceutyczne Polpharma